Ainos Inc (AIMD)

$2.47 +0.01 (0.41%)
Market Cap 10.31M
Revenue (ttm) 20,000.00
Net Income (ttm) -14.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74,300.00%
Debt to Equity Ratio 0.08
Volume 1,142,700
Avg Vol 79,815
Day's Range N/A - N/A
Shares Out 4.19M
Stochastic %K 13%
Beta 2.20
Analysts Strong Buy
Price Target N/A

Company Profile

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal h...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 869 2986
Address:
8880 Rio San Diego Drive, Suite 800, San Diego, United States
_www_larval_com_
_www_larval_com_ Aug. 4 at 3:53 PM
$AIMD just shot 4% higher to 1% (~1Mv) moments ago, follow for more volatility.
0 · Reply
Samuelstark
Samuelstark Aug. 4 at 3:10 PM
$AIMD dilution or shorts?
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 1:43 PM
$BTBD 27%[116%] $AIMD -6%[-6%] $VAPE -5%[7%] $ZEPP 5%[44%] $BINI -3%[-28%] most notable movement within the first minutes of trading.
0 · Reply
CupShaker
CupShaker Aug. 4 at 1:14 PM
$AIMD watched this pop to ~$3.30 range during pre-market hours. Probably nothing 👀
0 · Reply
maxxie29
maxxie29 Aug. 4 at 12:50 PM
$AIMD no buyers!!!
0 · Reply
GTM86
GTM86 Aug. 4 at 12:39 PM
$AIMD by far the worst ticker I own
0 · Reply
prasan2015
prasan2015 Aug. 4 at 12:19 PM
$AIMD $$$3+
0 · Reply
Enigma123
Enigma123 Aug. 4 at 12:15 PM
$AIMD news: Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/ainos-receives-tfda-approval-to-initiate-clinical-study-of-veldon-1056006
1 · Reply
2312132DD
2312132DD Aug. 4 at 12:13 PM
$AIMD $5
0 · Reply
CumulativeChaser
CumulativeChaser Aug. 4 at 10:19 AM
$PTHS $HSDT $APG $AIMD
0 · Reply
Latest News on AIMD
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome

Aug 4, 2025, 8:00 AM EDT - 11 hours ago

Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome

Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation

Jul 24, 2025, 8:00 AM EDT - 11 days ago

Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation

Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector

Jul 22, 2025, 8:00 AM EDT - 13 days ago

Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector

Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026

Jul 16, 2025, 8:00 AM EDT - 19 days ago

Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026

Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships

Jul 10, 2025, 8:00 AM EDT - 25 days ago

Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

Jul 7, 2025, 8:00 AM EDT - 4 weeks ago

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization

Jun 30, 2025, 8:00 AM EDT - 5 weeks ago

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

Jun 27, 2025, 8:00 AM EDT - 5 weeks ago

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

ASX

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

Jun 26, 2025, 11:00 AM EDT - 5 weeks ago

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Jun 24, 2025, 8:00 AM EDT - 5 weeks ago

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

Jun 17, 2025, 11:35 AM EDT - 6 weeks ago

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Jun 16, 2025, 8:00 AM EDT - 7 weeks ago

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Jun 3, 2025, 8:00 AM EDT - 2 months ago

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

May 29, 2025, 8:00 AM EDT - 2 months ago

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

May 22, 2025, 8:00 AM EDT - 2 months ago

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

May 19, 2025, 8:00 AM EDT - 2 months ago

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

May 14, 2025, 8:00 AM EDT - 2 months ago

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

Ainos Reports First Quarter 2025 Financial Results

May 12, 2025, 8:00 AM EDT - 3 months ago

Ainos Reports First Quarter 2025 Financial Results

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

Apr 30, 2025, 8:12 AM EDT - 3 months ago

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

ASX

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Apr 23, 2025, 8:00 AM EDT - 3 months ago

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Ainos and ugo Complete First Robotic Smell Integration in Japan

Apr 21, 2025, 8:00 AM EDT - 3 months ago

Ainos and ugo Complete First Robotic Smell Integration in Japan

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Apr 14, 2025, 8:00 AM EDT - 4 months ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Apr 11, 2025, 8:00 AM EDT - 4 months ago

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Mar 24, 2025, 5:00 PM EDT - 4 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

Mar 13, 2025, 9:00 AM EDT - 5 months ago

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More

ASX

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Mar 11, 2025, 9:00 AM EDT - 5 months ago

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

ASX

Ainos Reports Full Year 2024 Financial Results

Mar 7, 2025, 4:45 PM EST - 5 months ago

Ainos Reports Full Year 2024 Financial Results

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Mar 7, 2025, 1:30 PM EST - 5 months ago

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Mar 5, 2025, 10:00 AM EST - 5 months ago

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Jan 27, 2025, 10:00 AM EST - 6 months ago

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Jan 21, 2025, 10:00 AM EST - 6 months ago

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Jan 17, 2025, 9:00 AM EST - 7 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

Jan 13, 2025, 10:00 AM EST - 7 months ago

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 12:05 PM EST - 8 months ago

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Dec 18, 2024, 8:00 AM EST - 8 months ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Dec 13, 2024, 8:00 AM EST - 8 months ago

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Dec 4, 2024, 8:00 AM EST - 8 months ago

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Dec 2, 2024, 8:00 AM EST - 8 months ago

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Nov 13, 2024, 8:00 AM EST - 9 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Nov 11, 2024, 8:00 AM EST - 9 months ago

Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Nov 8, 2024, 8:00 AM EST - 9 months ago

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

Ainos Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 9 months ago

Ainos Reports Third Quarter 2024 Financial Results

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Oct 28, 2024, 8:00 AM EDT - 10 months ago

Ainos Expands Patent Portfolio With Strategic Shareholder's Cutting-Edge Technology Assets

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Oct 24, 2024, 10:50 AM EDT - 10 months ago

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Oct 7, 2024, 8:00 AM EDT - 10 months ago

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Sep 25, 2024, 8:00 AM EDT - 11 months ago

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Sep 24, 2024, 10:55 AM EDT - 11 months ago

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren's Syndrome

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Sep 23, 2024, 8:00 AM EDT - 11 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Sep 20, 2024, 8:00 AM EDT - 11 months ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Sep 17, 2024, 8:00 AM EDT - 11 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

_www_larval_com_
_www_larval_com_ Aug. 4 at 3:53 PM
$AIMD just shot 4% higher to 1% (~1Mv) moments ago, follow for more volatility.
0 · Reply
Samuelstark
Samuelstark Aug. 4 at 3:10 PM
$AIMD dilution or shorts?
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 4 at 1:43 PM
$BTBD 27%[116%] $AIMD -6%[-6%] $VAPE -5%[7%] $ZEPP 5%[44%] $BINI -3%[-28%] most notable movement within the first minutes of trading.
0 · Reply
CupShaker
CupShaker Aug. 4 at 1:14 PM
$AIMD watched this pop to ~$3.30 range during pre-market hours. Probably nothing 👀
0 · Reply
maxxie29
maxxie29 Aug. 4 at 12:50 PM
$AIMD no buyers!!!
0 · Reply
GTM86
GTM86 Aug. 4 at 12:39 PM
$AIMD by far the worst ticker I own
0 · Reply
prasan2015
prasan2015 Aug. 4 at 12:19 PM
$AIMD $$$3+
0 · Reply
Enigma123
Enigma123 Aug. 4 at 12:15 PM
$AIMD news: Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/ainos-receives-tfda-approval-to-initiate-clinical-study-of-veldon-1056006
1 · Reply
2312132DD
2312132DD Aug. 4 at 12:13 PM
$AIMD $5
0 · Reply
CumulativeChaser
CumulativeChaser Aug. 4 at 10:19 AM
$PTHS $HSDT $APG $AIMD
0 · Reply
TechFan6
TechFan6 Jul. 31 at 8:17 PM
Exploring U.S. service robotics stocks — use cases now go way beyond factories 👇 • $SERV – DoorDash spin-off doing last-mile delivery robots (RaaS model) • $RR – Hotel & restaurant service bots (delivery, cleaning, guidance) • $KSCP – Autonomous security robots in offices & campuses (B2G model) • $TNC – Legacy cleaning brand turned AI robot play (airports, retail) • $AIMD – AI Nose tech gives robots a “sense of smell” (industrial, medical, security) Service automation is here. Watch the rise of #RaaS, #AI, and smart sensing 🧠🤖 #Robotics #TechStocks #Automation #SmellTech #AIStocks $SERV $RR $KSCP $TNC $AIMD #AI #Robotics #TechStocks #DeliveryRobots #CleaningRobots #SecurityTech #SmellTech
1 · Reply
Supplement
Supplement Jul. 31 at 1:56 AM
$AIMD Really really bullish here post earnings call.
0 · Reply
TwongStocks
TwongStocks Jul. 30 at 10:39 PM
One month post-RS recap. $AIMD 1:5 RS on Jun 30, closed $2.83 Hit an intraday low of $2.324 the day of the RS, but so far has managed to stay above that. Peaked at $3.35 on Jul 3. Has not traded in the $3S since Jul 11, despite multiple PRs from the company since then. Today closed $2.61, down 7.77% from RS close.
0 · Reply
Supplement
Supplement Jul. 30 at 2:06 PM
$AIMD
0 · Reply
Supplement
Supplement Jul. 29 at 6:52 PM
$AIMD Seems to be sinking everyday more and more. Hopefully earnings is a beautiful thing coming up and we start to climb sooner than later.
0 · Reply
RayIngersoll776
RayIngersoll776 Jul. 28 at 3:01 PM
$AIMD plays in digital health, while AITX is showing growth so sharp it rivals companies trading at 20–25x revenue—AITX is at just 4x.
0 · Reply
_Swing_King_
_Swing_King_ Jul. 27 at 5:04 PM
$AIMD 🤔
0 · Reply
TechFan6
TechFan6 Jul. 25 at 3:54 PM
$AIMD Asia accounts for ~70% of global semiconductor manufacturing capacity and ~45% of EMS production. Japan alone produces 38% of the world’s industrial robots. In 2H 2025, $AIMD (Ainos Inc.) is set to focus on scaling AI Nose industrial applications, with execution centered in Asia.
0 · Reply
CupShaker
CupShaker Jul. 25 at 3:47 PM
Stinking (cheddar cheese stinking) up my portfolio right now but absolutely gradually throwing today's paycheck into $AVAX.X, $CLOV, $AIMD & $ARBE. Bottom of the barrel levels, but likely doubling my paycheck in a couple weeks.
2 · Reply
Supplement
Supplement Jul. 25 at 2:37 PM
$AIMD Let's get back to $3.30 +++
0 · Reply
VernSmith
VernSmith Jul. 24 at 10:05 PM
$AIMD I am convinced these guys will be having cocktails with Elon and Optimus in the not-so-far future. This is truly groundbreaking. The implications across the entire spectrum of business is astounding . Industrial, commercial, residential. I was in this before the reverse split at $.50. A millionaire maker no doubt. Pair this archer aviation and hot damn, we will be living like the Jetsons!!
0 · Reply
TechFan6
TechFan6 Jul. 24 at 6:16 PM
$AIMD
0 · Reply